Correlation Between Kineta and OncoVista Innovative

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kineta and OncoVista Innovative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kineta and OncoVista Innovative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kineta Inc and OncoVista Innovative Therapies, you can compare the effects of market volatilities on Kineta and OncoVista Innovative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kineta with a short position of OncoVista Innovative. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kineta and OncoVista Innovative.

Diversification Opportunities for Kineta and OncoVista Innovative

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Kineta and OncoVista is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kineta Inc and OncoVista Innovative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoVista Innovative and Kineta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kineta Inc are associated (or correlated) with OncoVista Innovative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoVista Innovative has no effect on the direction of Kineta i.e., Kineta and OncoVista Innovative go up and down completely randomly.

Pair Corralation between Kineta and OncoVista Innovative

If you would invest  0.01  in OncoVista Innovative Therapies on August 28, 2024 and sell it today you would earn a total of  0.00  from holding OncoVista Innovative Therapies or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy96.83%
ValuesDaily Returns

Kineta Inc  vs.  OncoVista Innovative Therapies

 Performance 
       Timeline  
Kineta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kineta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
OncoVista Innovative 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoVista Innovative Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward indicators, OncoVista Innovative is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Kineta and OncoVista Innovative Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kineta and OncoVista Innovative

The main advantage of trading using opposite Kineta and OncoVista Innovative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kineta position performs unexpectedly, OncoVista Innovative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoVista Innovative will offset losses from the drop in OncoVista Innovative's long position.
The idea behind Kineta Inc and OncoVista Innovative Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas